Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AR/Fayetteville
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fayetteville, AR

Studies commonly pay $75 to $4,500 per completed study

124 clinical trials are currently recruiting participants within 30 miles of Fayetteville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

124studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fayetteville right now

Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 490 participants sought
Highlands Oncology Group - Springdale /ID# 277132 — Springdale, Arkansas (8.2 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07155187)

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Bipolar Disorder, Bipolar Depression Phase 3 Interventional 400 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Xenon Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07172516)

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic Phase 3 Interventional 735 participants sought
Highlands Oncology Group ( Site 5405) — Springdale, Arkansas (8.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT05947851)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Malignant Melanoma Phase 2 Interventional 160 participants sought
Highlands Oncology Group ( Site 4042) — Springdale, Arkansas (8.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06961006)

Combining a Smartphone App With Medications to Manage Heavy Drinking

Alcohol Use Disorder (AUD) N/A Interventional 330 participants sought
Veterans Health Care System of the Ozarks, Fayetteville, AR — Fayetteville, Arkansas (0.8 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT06303778)

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

NSCLC Stage IV Phase 3 Interventional 507 participants sought
Highlands Oncology Group — Springdale, Arkansas (8.2 mi) · Sponsor: ImmunityBio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06745908)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

Muscle-invasive Urothelial Carcinoma Phase 2 Interventional 62 participants sought
Highlands Oncology Group. — Springdale, Arkansas (8.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06534983)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Major Depressive Disorder Phase 3 Interventional 450 participants sought
Woodland Research Northwest — Rogers, Arkansas (18.2 mi) · Sponsor: Xenon Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06775379)

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Phase 3 Interventional 2,130 participants sought
Research Site — Springdale, Arkansas (8.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07431281)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05939414)

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma (MM) Phase 1 Interventional 258 participants sought
Highlands Oncology Group, PA — Springdale, Arkansas (8.2 mi) · Sponsor: Shanghai Henlius Biotech
See eligibility & contact on ClinicalTrials.gov (NCT07477587)

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Atopic Dermatitis Phase 3 Interventional 200 participants sought
Clinical Trials Institute - Northwest Arkansas /ID# 267290 — Fayetteville, Arkansas (0.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06389136)

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) Phase 3 Interventional 975 participants sought
Retina Partners of Northwest Arkansas, PLLC — Springdale, Arkansas (8.2 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06541704)

Physical Activity and Community EmPOWERment Project

Intellectual Disability, Neurodevelopmental Disorders N/A Interventional 376 participants sought
University of Arkansas — Fayetteville, Arkansas (0.8 mi) · Sponsor: University of North Carolina, Chapel Hill
See eligibility & contact on ClinicalTrials.gov (NCT06740162)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 2 Interventional 111 participants sought
Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas (0.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061964)

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Pneumococcal Immunization, Healthy Volunteers Phase 3 Interventional 2,195 participants sought
Northwest Arkansas Pediatric Clinic- Site Number : 8400039 — Fayetteville, Arkansas (0.8 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07348692)

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Phase 3 Interventional 240 participants sought
Highlands Oncology Group — Fayetteville, Arkansas (0.8 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06784752)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Highlands Oncology Group, PA — Fayetteville, Arkansas (0.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)
Actively enrolling

Studies you may be able to join near Fayetteville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fayetteville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Initiatives Research

2233 Green Acres Rd, Fayetteville, AR 72703
(479) 575-9600

Clinical Trials Institute of Northwest Arkansas

1651 E Stearns St #110, Fayetteville, AR 72703
(479) 544-3483

UAMS Northwest Regional Campus

★ 3.8
1125 N College Ave, Fayetteville, AR 72703
(479) 713-8000

The Spero Clinic

★ 4.9 (242 reviews)
22 Colt Square Dr, Fayetteville, AR 72703
(479) 333-8422

Woodland Research Northwest

★ 4.3
609 W Dyke Rd, Rogers, AR 72758
(479) 927-3000

Pat Walker Health Center

★ 3.0
525 Garland Ave, Fayetteville, AR 72701
(479) 575-4451
"The ladies at the front desk are very welcoming and friendly. They are very outgoing and were more than happy to help me. I really appreciate the tim…"
— Miller Johnston, 5★

Pillar Clinical Research, Bentonville, Arkansas

★ 4.9
3200 NE Redhawk Dr, Bentonville, AR 72712
(479) 367-2688
"⭐⭐⭐⭐⭐<br><br>I had a great experience with Pillar Clinical Research. The staff was friendly, professional, and made me feel comfortable from the…"
— elexis Thomas, 5★

C & C Market Research

★ 4.1
4201 N Shiloh Dr #1820, Fayetteville, AR 72703
(479) 582-1127
"Tried calling the number says been disconnected ☹️😡"
— Elizabeth Ritcheson (Bettyjo), 1★

Northwest Arkansas Clinical Trials Center, PLLC

★ 5.0
599 S Horsebarn Rd #200, Rogers, AR 72758
(479) 876-8205

Clinical trials in Fayetteville: what's recruiting

The Fayetteville area currently has 124 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fayetteville, the most active research areas are:

  • Cancer & Oncology13 studies
  • Brain & Mental Health4 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Fayetteville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fayetteville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fayetteville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fayetteville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Fayetteville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Fayetteville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fayetteville typically complete one or two studies per year.

Paid clinical trials near Fayetteville

Other metros within reach

Springfield, MO147 Tulsa, OK182 Little Rock, AR509 Overland Park, KS1,030 Olathe, KS1,039 Kansas City, MO1,031 Kansas City, KS1,043 Topeka, KS111

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fayetteville Bladder Issues Due To Spinal Cord Injury in Fayetteville All conditions

More of AR

Little Rock509

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts